ПИРРОЛОТРИАЗИНОВЫЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ КИНАЗ

摘要

The present invention provides compounds of formula I
and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.